Beruflich Dokumente
Kultur Dokumente
morphine immediate
release
hydrocodone (Vicodin,
Lorcet, Norco, Hycet,
Lortab, Zamicet, Zydone)
hydromorphone
oxycodone (Percocet,
Oxycontin, Oxecta, Oxyfast,
Roxicodone)
oxymorphone (Opana,
Opana ER, Numorphan)
codiene (Tyl # 3, Tyl # 4)
tramadol (Ultram, Conzip,
Rybix, Ryzolt)
levorphanol (LevoDromoran)
methadone (Dolophine,
Methadose)
fentanyl (Duragesic)
meperidine (Demerol)
Brand availability
MSIR: 15,30 ($0.50)
Roxanol 2,4,20/ml ($1/ml)
supp: 5,10,20,30
Avinza:30,45,60,75,90,120
($520) Kadian:10,20,30,40,50,60,70,80,
100, 130,150,200 ($6- )
MSContin: 15,30,60,100,200 ($130/pill
for 200mg)
generic forms: 2.5/500,5/300, 5/325,
5/500, 7.5/300, 7.5/325, 7.5/500,
7.5/650, 7.5/750, 10/300, 10/325,
10/500, 10/650, 10/660,
7.5/325/15ml, 7.5/500/15ml,
10/325/15ml ($0.25 - 2)
Dilaudid: 2,4,8,1/ml ($9)
Exalgo ER: 8,12,16,32 ($19)
supp: 3
Percocet: 2.5/325, 5/325, 7.5/325,
7.5/500,10/325,10/650
Roxicodone: 5, 15, 30 ($0.5- 0.75)
Oxycontin (ER): 15, 15, 20, 30, 40, 60,
80 ($3-5)
10 mg
SC/IM/IV
$$
30 mg po
$$$
7.5 mg po
1.5 mg
SC/IM/IV
2-8 mg q3-4
20 mg po
5-15 mg q 4-6
$$$
epidural 1-6 mg
(M)
(M)
NONE
NONE
3 mg q6-8
NONE
NONE
(M)
200 mg po
130 mg IM
15-60 mg q4-6
120 mg po
100 mg IM
50-100 mg q 4-6
4 mg po
2 mg q 6-8
2 mg SC/IM/IV
20 mg po
10 mg IM
(variable)
(M)
(M)
12 hours
(M)
2-4 hours
24 hours
3-6 hours
2.5-10 mg
PO/SC/IM/IV q 8- 6-8 hours
12
0.1 SC/IM/IV
300 mg po
100 mg IM
2-4 hours
(M)
48-72 hours
50-150 mg q3-4
pent/naloxone
150 mg po
combo: 1-2 tabs
30 mg SC/IM/IV
q3-4
0.8 mg po
0.3 mg IM
nalbuphine (Nubain)
tapentadol (Nucynta)
10-20 mg
q4
(D)
(P)
(P)
(M)
notes
8-12 hours
10 mg po
10-20 mg q 4-6
1 mg SC/IM/IV
$$$
cate
gory
2-4 hours
$$$
rectal
dosing
8-24 hours
$$
2, 8 SL
parenteral dosing
2-4 hours
$$$
50/0.5
Duration of
Action
10-30 mg q3-4
2 mg ($2)
po dosing
30 mg po
$$$
po Morphine
equivalent
Opana: 5, 10
pentazocine (Talwin)
buprenorphine (Buprenex,
Subutex)
COS
T
75 mg po
butorphanol (Stadol)
0.4 mg IM
sufentanil (Sufenta)
0.2 mg IV
hepatic metabolism,
good for renal failure
transdermal dosing
toxic metabolites,
poor absorption
mixed
agonist/antagonist
mixed
agonist/antagonist
mixed
agonist/antagonist
mu receptor
antagonist
(M)
(P)